Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liuya Wei

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Medicine|January 28, 2020
Synthesis, oral bioavailability evaluation and antiplatelet aggregation activity of three derivatives of 3,4‑dihydroxyacetophenoneNa Sun, Mei Qu, Mengyu Wang, et al.
Frontiers in Microbiology|August 28, 2020
Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic BacteriaJing Kong, Zhuo-Xun Wu, Liuya Wei, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 11, 2024
Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin AXueming Li, Fenglian Zhang, Yu Ke, et al.
Cancer Pathogenesis and Therapy|July 19, 2024
Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancerSiddhant Shukla, Harsh Patel, Shuzhen Chen, et al.
Drug Discovery Today|December 28, 2014
Silver nanoparticles: synthesis, properties, and therapeutic applicationsLiuya Wei, Jingran Lu, Huizhong Xu, et al.
Biomaterials Advances|October 20, 2023
Composite porphyrin-based conjugated microporous polymer/graphene oxide capable of photo-triggered combinational antibacterial therapy and wound healingPeilei Chen, Runsong Ze, Xiaohui Xia, et al.
Drug Discovery Today|May 24, 2021
Recent progress on targeting leukemia stem cellsXiang-Yu Ma, Liuya Wei, Zining Lei, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 21, 2022
Research progress in overcoming ibrutinib drug resistanceXiang-Yu Ma, Min Zhao, Yi-Dong Li, et al.
Frontiers in Pharmacology|May 1, 2023
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibitionCongying Gao, Lei Zhang, Yun Xu, et al.
Frontiers in Pharmacology|May 16, 2022
The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements <i>via</i> Epigenetic ModificationJingfang Yao, Gentao Li, Zihui Cui, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Medicine|January 28, 2020
Synthesis, oral bioavailability evaluation and antiplatelet aggregation activity of three derivatives of 3,4‑dihydroxyacetophenoneNa Sun, Mei Qu, Mengyu Wang, et al.
Frontiers in Microbiology|August 28, 2020
Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic BacteriaJing Kong, Zhuo-Xun Wu, Liuya Wei, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 11, 2024
Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin AXueming Li, Fenglian Zhang, Yu Ke, et al.
Cancer Pathogenesis and Therapy|July 19, 2024
Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancerSiddhant Shukla, Harsh Patel, Shuzhen Chen, et al.
Drug Discovery Today|December 28, 2014
Silver nanoparticles: synthesis, properties, and therapeutic applicationsLiuya Wei, Jingran Lu, Huizhong Xu, et al.
Biomaterials Advances|October 20, 2023
Composite porphyrin-based conjugated microporous polymer/graphene oxide capable of photo-triggered combinational antibacterial therapy and wound healingPeilei Chen, Runsong Ze, Xiaohui Xia, et al.
Drug Discovery Today|May 24, 2021
Recent progress on targeting leukemia stem cellsXiang-Yu Ma, Liuya Wei, Zining Lei, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 21, 2022
Research progress in overcoming ibrutinib drug resistanceXiang-Yu Ma, Min Zhao, Yi-Dong Li, et al.
Frontiers in Pharmacology|May 1, 2023
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibitionCongying Gao, Lei Zhang, Yun Xu, et al.
Frontiers in Pharmacology|May 16, 2022
The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements <i>via</i> Epigenetic ModificationJingfang Yao, Gentao Li, Zihui Cui, et al.
Pageof 5